CytoSorb linked to 37% less severe bleeding in urgent CABG patients taking ticagrelor
A 587-patient matched real-world analysis found severe bleeding in 21.8% of CytoSorb-treated urgent CABG patients versus 34.5% of controls, strengthening CytoSorbents’ planned DrugSorb-ATR De Novo resubmission.